 | • レポートコード：20QY06-08490 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、慢性蕁麻疹または蕁麻疹薬のグローバル市場について種類別（GDC-0853、GSK-2646264、BF-Derm-1、ビラスチン、その他）、用途別（クリニック、病院、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・慢性蕁麻疹または蕁麻疹薬市場の概要 ・世界の主要地域別慢性蕁麻疹または蕁麻疹薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の慢性蕁麻疹または蕁麻疹薬市場規模2015-2026：種類別（GDC-0853、GSK-2646264、BF-Derm-1、ビラスチン、その他） ・世界の慢性蕁麻疹または蕁麻疹薬市場規模2015-2026：用途別（クリニック、病院、その他） ・慢性蕁麻疹または蕁麻疹薬の北米市場規模2015-2020 ・慢性蕁麻疹または蕁麻疹薬のヨーロッパ市場規模2015-2020 ・慢性蕁麻疹または蕁麻疹薬の中国市場規模2015-2020 ・慢性蕁麻疹または蕁麻疹薬の日本市場規模2015-2020 ・慢性蕁麻疹または蕁麻疹薬の東南アジア市場規模2015-2020 ・慢性蕁麻疹または蕁麻疹薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AstraZeneca Plc、Biofrontera AG、ELORAC, Inc.、Faes Farma, SA、Genentech, Inc.、GlaxoSmithKline Plc、J Uriach Y Compania, S.A.、Mabtech Limited、Merck & Co., Inc.、Mycenax Biotech Inc.、Novartis AG、Panacea Biotec Limited） ・慢性蕁麻疹または蕁麻疹薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・慢性蕁麻疹または蕁麻疹薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Chronic Urticaria Or Hives Drug Market
The global Chronic Urticaria Or Hives Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Chronic Urticaria Or Hives Drug Scope and Market Size
The global Chronic Urticaria Or Hives Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Urticaria Or Hives Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chronic Urticaria Or Hives Drug market is segmented into
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Segment by Application, the Chronic Urticaria Or Hives Drug market is segmented into
Clinic
Hospital
Others
The Chronic Urticaria Or Hives Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Chronic Urticaria Or Hives Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chronic Urticaria Or Hives Drug Market Share Analysis
Chronic Urticaria Or Hives Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Urticaria Or Hives Drug business, the date to enter into the Chronic Urticaria Or Hives Drug market, Chronic Urticaria Or Hives Drug product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Table of Contents
1 Chronic Urticaria Or Hives Drug Market Overview
1.1 Chronic Urticaria Or Hives Drug Product Scope
1.2 Chronic Urticaria Or Hives Drug Segment by Type
1.2.1 Global Chronic Urticaria Or Hives Drug Sales by Type (2020-2026)
1.2.2 GDC-0853
1.2.3 GSK-2646264
1.2.4 BF-Derm-1
1.2.5 Bilastine
1.2.6 Others
1.3 Chronic Urticaria Or Hives Drug Segment by Application
1.3.1 Global Chronic Urticaria Or Hives Drug Sales Comparison by Application (2020-2026)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Chronic Urticaria Or Hives Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Chronic Urticaria Or Hives Drug Sales Growth Rate (2015-2026)
1.4.2 Global Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Chronic Urticaria Or Hives Drug Price Trends (2015-2026)
2 Chronic Urticaria Or Hives Drug Estimate and Forecast by Region
2.1 Global Chronic Urticaria Or Hives Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Chronic Urticaria Or Hives Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2015-2020)
2.3 Global Chronic Urticaria Or Hives Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Chronic Urticaria Or Hives Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Chronic Urticaria Or Hives Drug Estimates and Projections (2015-2026)
2.4.2 Europe Chronic Urticaria Or Hives Drug Estimates and Projections (2015-2026)
2.4.3 China Chronic Urticaria Or Hives Drug Estimates and Projections (2015-2026)
2.4.4 Japan Chronic Urticaria Or Hives Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Chronic Urticaria Or Hives Drug Estimates and Projections (2015-2026)
2.4.6 India Chronic Urticaria Or Hives Drug Estimates and Projections (2015-2026)
3 Global Chronic Urticaria Or Hives Drug Competition Landscape by Players
3.1 Global Top Chronic Urticaria Or Hives Drug Players by Sales (2015-2020)
3.2 Global Top Chronic Urticaria Or Hives Drug Players by Revenue (2015-2020)
3.3 Global Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2019)
3.4 Global Chronic Urticaria Or Hives Drug Average Price by Company (2015-2020)
3.5 Manufacturers Chronic Urticaria Or Hives Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Chronic Urticaria Or Hives Drug Players (Opinion Leaders)
4 Global Chronic Urticaria Or Hives Drug Market Size by Type
4.1 Global Chronic Urticaria Or Hives Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Chronic Urticaria Or Hives Drug Price by Type (2014-2020)
4.2 Global Chronic Urticaria Or Hives Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Chronic Urticaria Or Hives Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Chronic Urticaria Or Hives Drug Price Forecast by Type (2021-2026)
5 Global Chronic Urticaria Or Hives Drug Market Size by Application
5.1 Global Chronic Urticaria Or Hives Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Chronic Urticaria Or Hives Drug Price by Application (2015-2020)
5.2 Global Chronic Urticaria Or Hives Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Chronic Urticaria Or Hives Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Urticaria Or Hives Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Urticaria Or Hives Drug Price Forecast by Application (2021-2026)
3 North America Chronic Urticaria Or Hives Drug Market Facts & Figures
3.2 North America Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
3.3 North America Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
3.4 North America Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
4 Europe Chronic Urticaria Or Hives Drug Market Facts & Figures
4.2 Europe Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
4.3 Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
4.4 Europe Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
5 China Chronic Urticaria Or Hives Drug Market Facts & Figures
5.2 China Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
5.3 China Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
5.4 China Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
6 Japan Chronic Urticaria Or Hives Drug Market Facts & Figures
6.2 Japan Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
6.3 Japan Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
6.4 Japan Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Chronic Urticaria Or Hives Drug Market Facts & Figures
7.2 Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
8 India Chronic Urticaria Or Hives Drug Market Facts & Figures
8.2 India Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
8.3 India Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
8.4 India Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Chronic Urticaria Or Hives Drug Business
12.1 AstraZeneca Plc
12.1.1 AstraZeneca Plc Chronic Urticaria Or Hives Drug Corporation Information
12.1.2 AstraZeneca Plc Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Products Offered
12.1.5 AstraZeneca Plc Recent Development
12.2 Biofrontera AG
12.2.1 Biofrontera AG Chronic Urticaria Or Hives Drug Corporation Information
12.2.2 Biofrontera AG Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Products Offered
12.2.5 Biofrontera AG Recent Development
12.3 ELORAC, Inc.
12.3.1 ELORAC, Inc. Chronic Urticaria Or Hives Drug Corporation Information
12.3.2 ELORAC, Inc. Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Products Offered
12.3.5 ELORAC, Inc. Recent Development
12.4 Faes Farma, SA
12.4.1 Faes Farma, SA Chronic Urticaria Or Hives Drug Corporation Information
12.4.2 Faes Farma, SA Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Products Offered
12.4.5 Faes Farma, SA Recent Development
12.5 Genentech, Inc.
12.5.1 Genentech, Inc. Chronic Urticaria Or Hives Drug Corporation Information
12.5.2 Genentech, Inc. Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Products Offered
12.5.5 Genentech, Inc. Recent Development
12.6 GlaxoSmithKline Plc
12.6.1 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Corporation Information
12.6.2 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Products Offered
12.6.5 GlaxoSmithKline Plc Recent Development
12.7 J Uriach Y Compania, S.A.
12.7.1 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Corporation Information
12.7.2 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Products Offered
12.7.5 J Uriach Y Compania, S.A. Recent Development
12.8 Mabtech Limited
12.8.1 Mabtech Limited Chronic Urticaria Or Hives Drug Corporation Information
12.8.2 Mabtech Limited Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Products Offered
12.8.5 Mabtech Limited Recent Development
12.9 Merck & Co., Inc.
12.9.1 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Corporation Information
12.9.2 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Products Offered
12.9.5 Merck & Co., Inc. Recent Development
12.10 Mycenax Biotech Inc.
12.10.1 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Corporation Information
12.10.2 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Products Offered
12.10.5 Mycenax Biotech Inc. Recent Development
12.11 Novartis AG
12.11.1 Novartis AG Chronic Urticaria Or Hives Drug Corporation Information
12.11.2 Novartis AG Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis AG Chronic Urticaria Or Hives Drug Products Offered
12.11.5 Novartis AG Recent Development
12.12 Panacea Biotec Limited
12.12.1 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Corporation Information
12.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Business Overview and Total Revenue
12.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Products Offered
12.12.5 Panacea Biotec Limited Recent Development
13 Chronic Urticaria Or Hives Drug Manufacturing Cost Analysis
13.1 Chronic Urticaria Or Hives Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
13.4 Chronic Urticaria Or Hives Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Chronic Urticaria Or Hives Drug Distributors List
14.3 Chronic Urticaria Or Hives Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Chronic Urticaria Or Hives Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2015-2020)
Table 6. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Chronic Urticaria Or Hives Drug Revenue Share by Region (2015-2020)
Table 8. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Chronic Urticaria Or Hives Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Chronic Urticaria Or Hives Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Chronic Urticaria Or Hives Drug Sales Share by Company (2015-2020)
Table 14. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Chronic Urticaria Or Hives Drug Revenue Share by Company (2015-2020)
Table 16. Global Chronic Urticaria Or Hives Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2019)
Table 17. Global Chronic Urticaria Or Hives Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Chronic Urticaria Or Hives Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Chronic Urticaria Or Hives Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Chronic Urticaria Or Hives Drug Players
Table 22. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Chronic Urticaria Or Hives Drug Sales Share by Type (2015-2020)
Table 24. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Chronic Urticaria Or Hives Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Chronic Urticaria Or Hives Drug Sales Share by Type (2021-2026)
Table 27. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Chronic Urticaria Or Hives Drug Revenue Share by Type (2021-2026)
Table 29. Global Chronic Urticaria Or Hives Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Chronic Urticaria Or Hives Drug Sales Share by Application (2015-2020)
Table 32. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Chronic Urticaria Or Hives Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Chronic Urticaria Or Hives Drug Sales Share by Application (2021-2026)
Table 36. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Chronic Urticaria Or Hives Drug Revenue Share by Application (2021-2026)
Table 38. Global Chronic Urticaria Or Hives Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Chronic Urticaria Or Hives Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
Table 41. United States Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
Table 43. United States Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
Table 51. China Chronic Urticaria Or Hives Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
Table 53. China Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
Table 55. China Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Chronic Urticaria Or Hives Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Chronic Urticaria Or Hives Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
Table 69. India Chronic Urticaria Or Hives Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Chronic Urticaria Or Hives Drug Sales Market Share by Company (2015-2020)
Table 71. India Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Chronic Urticaria Or Hives Drug Sales Market Share by Type (2015-2020)
Table 73. India Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Chronic Urticaria Or Hives Drug Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca Plc Corporation Information
Table 76. AstraZeneca Plc Description and Business Overview
Table 77. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product
Table 79. AstraZeneca Plc Recent Development
Table 80. Biofrontera AG Corporation Information
Table 81. Biofrontera AG Description and Business Overview
Table 82. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Biofrontera AG Chronic Urticaria Or Hives Drug Product
Table 84. Biofrontera AG Recent Development
Table 85. ELORAC, Inc. Corporation Information
Table 86. ELORAC, Inc. Description and Business Overview
Table 87. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product
Table 89. ELORAC, Inc. Recent Development
Table 90. Faes Farma, SA Corporation Information
Table 91. Faes Farma, SA Description and Business Overview
Table 92. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Faes Farma, SA Chronic Urticaria Or Hives Drug Product
Table 94. Faes Farma, SA Recent Development
Table 95. Genentech, Inc. Corporation Information
Table 96. Genentech, Inc. Description and Business Overview
Table 97. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Genentech, Inc. Chronic Urticaria Or Hives Drug Product
Table 99. Genentech, Inc. Recent Development
Table 100. GlaxoSmithKline Plc Corporation Information
Table 101. GlaxoSmithKline Plc Description and Business Overview
Table 102. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product
Table 104. GlaxoSmithKline Plc Recent Development
Table 105. J Uriach Y Compania, S.A. Corporation Information
Table 106. J Uriach Y Compania, S.A. Description and Business Overview
Table 107. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product
Table 109. J Uriach Y Compania, S.A. Recent Development
Table 110. Mabtech Limited Corporation Information
Table 111. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Mabtech Limited Description and Business Overview
Table 113. Mabtech Limited Chronic Urticaria Or Hives Drug Product
Table 114. Mabtech Limited Recent Development
Table 115. Merck & Co., Inc. Corporation Information
Table 116. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Merck & Co., Inc. Description and Business Overview
Table 118. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product
Table 119. Merck & Co., Inc. Recent Development
Table 120. Mycenax Biotech Inc. Corporation Information
Table 121. Mycenax Biotech Inc. Description and Business Overview
Table 122. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product
Table 124. Mycenax Biotech Inc. Recent Development
Table 125. Novartis AG Corporation Information
Table 126. Novartis AG Description and Business Overview
Table 127. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Novartis AG Chronic Urticaria Or Hives Drug Product
Table 129. Novartis AG Recent Development
Table 130. Panacea Biotec Limited Corporation Information
Table 131. Panacea Biotec Limited Description and Business Overview
Table 132. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product
Table 134. Panacea Biotec Limited Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Chronic Urticaria Or Hives Drug Distributors List
Table 138. Chronic Urticaria Or Hives Drug Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Urticaria Or Hives Drug Product Picture
Figure 2. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Chronic Urticaria Or Hives Drug Market Share by Application in 2020 & 2026
Figure 6. Clinic Examples
Figure 7. Hospital Examples
Figure 8. Others Examples
Figure 9. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Chronic Urticaria Or Hives Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Chronic Urticaria Or Hives Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Chronic Urticaria Or Hives Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Chronic Urticaria Or Hives Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Chronic Urticaria Or Hives Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Chronic Urticaria Or Hives Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Chronic Urticaria Or Hives Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Chronic Urticaria Or Hives Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Chronic Urticaria Or Hives Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Chronic Urticaria Or Hives Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Chronic Urticaria Or Hives Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Chronic Urticaria Or Hives Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Chronic Urticaria Or Hives Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Chronic Urticaria Or Hives Drug Players Market Share by Revenue in Chronic Urticaria Or Hives Drug 2015 & 2019
Figure 27. Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Chronic Urticaria Or Hives Drug Revenue Share by Type (2015-2020)
Figure 29. Global Chronic Urticaria Or Hives Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Chronic Urticaria Or Hives Drug Revenue Share by Application (2015-2020)
Figure 31. Global Chronic Urticaria Or Hives Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2019
Figure 33. United States Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2019
Figure 34. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2019
Figure 35. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2019
Figure 36. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Application in 2019
Figure 37. China Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2019
Figure 38. China Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2019
Figure 39. China Chronic Urticaria Or Hives Drug Sales Market Share by Application in 2019
Figure 40. Japan Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2019
Figure 41. Japan Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2019
Figure 42. Japan Chronic Urticaria Or Hives Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Chronic Urticaria Or Hives Drug Sales Market Share by Application in 2019
Figure 46. India Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2019
Figure 47. India Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2019
Figure 48. India Chronic Urticaria Or Hives Drug Sales Market Share by Application in 2019
Figure 49. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Biofrontera AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. ELORAC, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Faes Farma, SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Genentech, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. J Uriach Y Compania, S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Mabtech Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mycenax Biotech Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Panacea Biotec Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Chronic Urticaria Or Hives Drug
Figure 63. Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
Figure 64. Chronic Urticaria Or Hives Drug Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
慢性炎症性脱髄性多発神経障害薬の世界市場レポート2020 Market Analysis and Insights: Global Chronic Inflammatory Demyelinating Polyneuropathy Drug Market The global Chronic Inflammatory Demyelinating Polyneuropathy Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026…- 抗痛風薬の世界市場レポート2020 Gout is a form of inflammatory arthritis characterized by recurrent attacks of a red, tender, hot, and swollen joint. Pain typically comes on rapidly in less than twelve hours.The joint at the base of the big toe is affected in about half of cases.It may also result in tophi, kidney stones, or urate…
- 慢性膵炎苦痛の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chronic Pancreatitis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Pancreatiti…
- 柔毛膜性生殖腺刺激ホルモンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chronic Gonadotropin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Gonadotropin mar…
- 慢性腰痛治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chronic Low Back Pain Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Low B…